GO:0006479 protein methylation: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006479 (protein methylation) is the biological process of adding a methyl group to a protein amino acid, using S-adenosylmethionine as the methyl donor.
• Protein methylation occurs on lysine, arginine, carboxyl groups, and other residues, and is not limited to histones; many non-histone proteins are methylated.
• Methylation is written by methyltransferases, erased by demethylases, and read by effector proteins, forming a dynamic regulatory system.
• Dysregulated protein methylation is linked to cancer, neurodegeneration, and metabolic disorders.
• Large-scale LC-MS/MS and bioinformatics approaches enable systematic mapping of the methylproteome.
• CRISPR knockout, point-mutation, knock-in, and overexpression models are essential to dissect causal roles of methylation writers, erasers, and readers.
Description
Protein methylation (GO:0006479) is a fundamental post-translational modification defined as the addition of a methyl group to a protein amino acid, with the methyl group derived from methane by removal of a hydrogen atom. This process is catalyzed by protein methyltransferases that transfer a methyl group from S-adenosylmethionine to acceptor residues such as lysine, arginine, and carboxyl groups. Far from being restricted to histones, protein methylation targets a wide range of nuclear, cytoplasmic, and mitochondrial proteins, influencing their stability, interactions, and catalytic activity. Researchers study protein methylation because it regulates gene expression, signal transduction, RNA processing, and memory formation, and its dysregulation contributes to cancer, neurological disorders, and metabolic diseases. The dynamic nature of methylation is governed by the coordinated action of writers, erasers, and readers, making it a rich area for therapeutic targeting and biomarker discovery.
protein methylation At A Glance
| GO ID | GO:0006479 |
|---|---|
| GO term | protein methylation |
| Ontology | biological_process |
| Synonym | protein amino acid methylation |
| Major function | Addition of a methyl group to a protein amino acid, regulating protein function, interactions, and stability |
| Methyl donor | S-adenosylmethionine (SAM) |
| Major enzyme classes | Protein lysine methyltransferases (PKMTs), protein arginine methyltransferases (PRMTs), protein carboxyl methyltransferases (PCMTs) |
| Reversibility | Reversed by demethylases such as LSD1 and JmjC-domain enzymes |
| Subcellular locations | Nucleus, cytoplasm, mitochondria |
What Is GO:0006479?
According to the Gene Ontology, GO:0006479 (protein methylation) is the biological process in which a methyl group is added to a protein amino acid. The methyl group is derived from methane by the removal of a hydrogen atom. This definition encompasses methylation of lysine, arginine, carboxyl groups, and other amino acid side chains, and includes both histone and non-histone protein substrates.
Why Is protein methylation Important in Cell Biology?
Protein methylation is critically important because it serves as a dynamic and reversible regulatory mark that controls protein activity, localization, and interactions across diverse cellular processes. It is essential for epigenetic regulation, RNA processing, signal transduction, and memory formation, and its disruption is implicated in cancer, neurodegeneration, and metabolic disorders. Understanding protein methylation provides mechanistic insights into disease and offers opportunities for targeted therapeutic intervention.
• Regulates gene expression through histone lysine methylation, affecting chromatin structure and transcription.
• Controls non-histone protein functions, including RNA-binding proteins and signaling molecules.
• Plays a role in memory formation via protein carboxyl methylation.
• Dysregulation is linked to multiple cancers through altered histone and non-histone methylation.
• Contributes to mitochondrial function through methylation of mitochondrial proteins.
• Involved in adrenal medullary cell biology via protein-carboxyl methylation.
• Provides biomarkers and therapeutic targets for precision medicine.
• Enables large-scale methylproteome mapping for discovery of new regulatory pathways.
• Impacts RNA processing through methylation of poly(A)-binding protein.
• Offers a paradigm for studying writer-eraser-reader networks in cell biology.
What Happens During protein methylation?
Methyl group transfer from SAM
In simple terms: A methyl group is handed over from a donor molecule to a protein.
Protein methylation begins with the binding of S-adenosylmethionine (SAM) by a methyltransferase enzyme. The enzyme catalyzes the transfer of the methyl group from SAM to a specific amino acid side chain on the target protein, such as lysine or arginine. This reaction is highly specific and depends on the recognition of consensus sequences or structural motifs in the substrate.
Lysine and arginine methylation
In simple terms: Different amino acids can receive methyl groups, each with distinct consequences.
Lysine residues can be mono-, di-, or tri-methylated by protein lysine methyltransferases (PKMTs), while arginine residues can be mono- or di-methylated (symmetrically or asymmetrically) by protein arginine methyltransferases (PRMTs). These distinct methylation states create docking sites for reader proteins that interpret the mark and translate it into downstream effects.
Carboxyl methylation
In simple terms: Methyl groups can also be added to carboxyl groups on proteins.
Protein carboxyl methylation, catalyzed by protein carboxyl methyltransferases (PCMTs), modifies carboxyl groups on proteins such as those involved in signal transduction and memory. This type of methylation is often reversible and can modulate protein-protein interactions and stability.
Demethylation and reversibility
In simple terms: Methyl marks can be removed by enzymes called demethylases.
The dynamic nature of protein methylation is maintained by demethylases, including LSD1 and JmjC-domain-containing enzymes, which remove methyl groups from lysine residues. This reversibility allows cells to rapidly respond to signals and ensures that methylation is not a permanent modification.
Reading and downstream effects
In simple terms: Reader proteins recognize methyl marks and trigger cellular responses.
Methylated proteins are recognized by reader domains such as chromodomains, Tudor domains, and PHD fingers, which recruit additional factors to modulate transcription, RNA processing, or signaling. These reader-mediated interactions ultimately determine the functional outcome of methylation.
Key Genes Involved in GO:0006479 protein methylation
The following genes encode the major writers, erasers, and readers of protein methylation, as well as representative substrates, and are widely studied in the context of GO:0006479.
| Gene | Major Role | Research Relevance |
|---|---|---|
| EHMT2 (G9a) | Histone lysine methyltransferase | H3K9me1/2 writer; implicated in cancer and memory |
| SUV39H1 | Histone lysine methyltransferase | H3K9me3 writer; heterochromatin formation |
| EZH2 | Histone lysine methyltransferase | H3K27me3 writer; Polycomb repression in cancer |
| SETD7 | Histone lysine methyltransferase | H3K4me1 writer; transcriptional regulation |
| PRMT1 | Protein arginine methyltransferase | Asymmetric arginine methylation; RNA processing |
| PRMT5 | Protein arginine methyltransferase | Symmetric arginine methylation; splicing regulation |
| CARM1 (PRMT4) | Protein arginine methyltransferase | Transcriptional coactivator methylation |
| LSD1 (KDM1A) | Lysine demethylase | Removes H3K4me1/2; oncogenic and neuronal roles |
| KDM4A (JMJD2A) | Lysine demethylase | Removes H3K9me2/3; cancer progression |
| KDM6A (UTX) | Lysine demethylase | Removes H3K27me3; developmental regulation |
| PCMT1 | Protein carboxyl methyltransferase | Repairs isoaspartyl residues; memory and aging |
| PABPN1 | Poly(A)-binding protein | Arginine-methylated by PRMTs; RNA processing |
| TP53 | Tumor suppressor | Methylated at lysine residues; regulates apoptosis |
| HSP90 | Chaperone | Methylated by SMYD2; affects client protein folding |
| SMYD2 | Lysine methyltransferase | Methylates p53 and HSP90; cancer |
| SETDB1 | Histone lysine methyltransferase | H3K9me3 writer; gene silencing |
| DNMT1 | DNA methyltransferase | Crosstalk with histone methylation |
How Is protein methylation Regulated?
Protein methylation is regulated at multiple levels. The expression and activity of methyltransferases and demethylases are controlled by signaling pathways, including growth factor signaling and metabolic cues. For example, the availability of S-adenosylmethionine (SAM) links methylation to cellular metabolism, and enzymes such as PRMTs can be regulated by post-translational modifications and interacting proteins. Additionally, demethylases like LSD1 are subject to transcriptional and post-transcriptional control, ensuring dynamic methylation states. In mitochondria, protein methylation is regulated by the import of methyltransferases and the local SAM pool.
protein methylation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| EZH2 | Cancer (lymphoma, breast, prostate) | Knockout and point-mutation cell lines to assess H3K27me3 and proliferation |
| LSD1 (KDM1A) | Cancer, neurodevelopmental disorders | Overexpression and knockout models to study demethylation effects |
| PCMT1 | Neurodegeneration, aging | Knockout mice and cell lines to evaluate protein repair and memory |
| PRMT5 | Cancer, splicing dysregulation | Knockdown and knock-in of methylation-deficient mutants |
| PABPN1 | Oculopharyngeal muscular dystrophy | Arginine methylation-deficient knock-in models |
Cancer
Dysregulated protein methylation is a hallmark of many cancers. Overexpression or mutation of histone methyltransferases such as EZH2 and EHMT2 leads to aberrant gene silencing that promotes tumorigenesis. Similarly, demethylases like LSD1 and KDM4A are often overexpressed in cancers and correlate with poor prognosis. Non-histone methylation, including that of p53 and HSP90, also contributes to cancer cell survival and proliferation.
Neurodegeneration and memory
Protein carboxyl methylation plays a role in memory formation, and its impairment is associated with cognitive decline. In adrenal medullary cells, protein-carboxyl methylation is involved in secretory function, linking methylation to neuroendocrine regulation. Dysregulation of arginine methylation of RNA-binding proteins such as PABPN1 has been implicated in neurodegenerative disorders.
Mitochondrial dysfunction
Mitochondrial protein methylation is emerging as a regulator of oxidative phosphorylation and mitochondrial dynamics. Alterations in mitochondrial methyltransferases or SAM metabolism can lead to mitochondrial dysfunction, which is associated with metabolic and neurodegenerative diseases.
From protein methylation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a methyltransferase affect global methylation? | CRISPR knockout cell line followed by LC-MS/MS |
| Does a specific methylation site regulate protein function? | Point-mutation knock-in of the acceptor residue |
| Can a reader domain be tagged for localization studies? | Tagged knock-in of the reader gene |
| Does overexpression of a demethylase alter gene expression? | Doxycycline-inducible overexpression cell line |
| What is the role of mitochondrial methylation? | Knockout of mitochondrial methyltransferase in cell lines |
| How does SAM availability affect methylation? | Metabolic perturbation combined with methylproteomics |
How to Study the protein methylation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| LC-MS/MS methylproteomics | Global and site-specific methylation | Mapping methylproteome in cancer cells |
| Western blot with methyl-specific antibodies | Levels of specific methyl marks | Validating changes after drug treatment |
| Immunoprecipitation | Protein-protein interactions of methylated proteins | Identifying reader proteins |
| CRISPR knockout screening | Genes required for methylation | Discovering regulators of methyltransferases |
| RNA-seq | Transcriptional changes upon methylation perturbation | Assessing downstream effects |
| ChIP-seq | Genome-wide localization of histone methylation | Mapping chromatin states |
| Proximity ligation assay | In situ interactions of methylated proteins | Visualizing methylation-dependent complexes |
| Metabolic labeling with 13C-methionine | Methyl group turnover | Measuring dynamic methylation |
LC-MS/MS-based methylproteomics
Large-scale analysis of protein methylation is achieved by enriching methylated peptides using antibodies or chemical methods, followed by LC-MS/MS. This approach enables site-specific mapping of lysine and arginine methylation across the proteome.
Antibody-based detection
Site-specific antibodies against methylated lysine or arginine residues are used in Western blotting, immunoprecipitation, and immunofluorescence to detect and quantify methylation changes in cells and tissues.
CRISPR screening
Genome-wide CRISPR knockout or activation screens can identify genes that regulate protein methylation levels or that confer sensitivity to methylation inhibitors.
Bioinformatics and pathway analysis
Computational analysis of methylproteomics data, including motif discovery and pathway enrichment, helps identify regulatory networks and crosstalk with other post-translational modifications.
How CRISPR Can Be Used to Study GO:0006479 protein methylation
Knockout
CRISPR knockout of methyltransferase or demethylase genes is used to abolish specific methylation marks and assess downstream cellular phenotypes, such as proliferation, differentiation, or drug sensitivity.
Point Mutation
Point mutations can be introduced into the catalytic domain of methyltransferases or into acceptor residues of substrate proteins to dissect the functional significance of individual methylation sites.
Knock-in
Knock-in of tagged versions of methylation writers, erasers, or readers allows for live-cell imaging, immunoprecipitation, and proteomic identification of interacting partners.
Overexpression
Overexpression of wild-type or mutant methyltransferases/demethylases via CRISPR activation or lentiviral delivery enables gain-of-function studies to test sufficiency in driving phenotypes.
How EDITGENE Supports protein methylation Research
Researchers studying protein methylation-related genes often need to determine whether a candidate gene is causally involved in a specific methylation event or disease phenotype. This requires precise genetic models that can isolate the contribution of individual writers, erasers, readers, or substrate residues. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate such investigations.
Contact EDITGENE today to design your custom CRISPR model for protein methylation research.
Frequently Asked Questions About protein methylation
What is protein methylation (GO:0006479)?
Protein methylation is the biological process of adding a methyl group to a protein amino acid, using S-adenosylmethionine as the donor, and is involved in regulating protein function and interactions.
What genes are involved in protein methylation?
Key genes include methyltransferases such as EHMT2, EZH2, PRMT1, and PRMT5, demethylases such as LSD1 and KDM4A, and substrate proteins like p53 and PABPN1.
How is protein methylation regulated?
It is regulated by the expression and activity of writers and erasers, by SAM availability, and by signaling pathways that control their function.
What diseases are associated with protein methylation?
Dysregulated methylation is linked to cancer, neurodegeneration, and mitochondrial dysfunction.
What methods are used to study protein methylation?
LC-MS/MS methylproteomics, antibody-based detection, CRISPR screens, and bioinformatics are commonly used.
Can CRISPR be used to study protein methylation?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect methylation pathways.
What is the role of protein carboxyl methylation?
Protein carboxyl methylation is involved in memory formation and adrenal medullary cell function.
How does mitochondrial protein methylation work?
Mitochondrial proteins can be methylated by specific methyltransferases, and this process regulates mitochondrial function.
What is the difference between lysine and arginine methylation?
Lysine methylation can be mono-, di-, or tri-methylated, while arginine methylation can be mono- or di-methylated (symmetric or asymmetric), each with distinct readers and functions.
Why is protein methylation important for drug discovery?
Because it is reversible and often dysregulated in disease, methylation enzymes are attractive therapeutic targets.
Conclusion
Protein methylation (GO:0006479) is a pervasive and dynamic post-translational modification that regulates diverse cellular processes through the coordinated action of writers, erasers, and readers. Its involvement in cancer, neurodegeneration, and mitochondrial function underscores its importance as a research focus and therapeutic target. Advances in methylproteomics and CRISPR-based models continue to illuminate the complex roles of protein methylation in health and disease.
References
- 1. Małecki JM et al.. 2022. Protein methylation in mitochondria.. J Biol Chem 298(4):101791 PMID: 35247388
- 2. Li Z et al.. 2009. Protein carboxyl methylation and the biochemistry of memory.. Biol Chem 390(11):1087-96 PMID: 19747079
- 3. Hyun K et al.. 2017. Writing, erasing and reading histone lysine methylations.. Exp Mol Med 49(4):e324 PMID: 28450737
- 4. Clarke SG. 2013. Protein methylation at the surface and buried deep: thinking outside the histone box.. Trends Biochem Sci 38(5):243-52 PMID: 23490039
- 5. Wang Q et al.. 2017. Strategies for large-scale analysis of non-histone protein methylation by LC-MS/MS.. Analyst 142(19):3536-3548 PMID: 28853452
- 6. Gagnon C et al.. 1988. Protein-carboxyl methylation in adrenal medullary cells.. Cell Mol Neurobiol 8(1):95-103 PMID: 3042145
- 7. Lanouette S et al.. 2014. The functional diversity of protein lysine methylation.. Mol Syst Biol 10(4):724 PMID: 24714364
- 8. Wahle E et al.. 2013. Methylation of the nuclear poly(A)-binding protein by type I protein arginine methyltransferases - how and why.. Biol Chem 394(8):1029-43 PMID: 23412876
